Browsing byAuthorButow, P

Jump to a point in the index:
Showing results 1 to 20 of 43  next >
Issue DateTitleAuthor(s)
2022-08Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.Best, MC; Butow, P; Savard, J; Jacobs, C; Bartley, N; Davies, G; Napier, CE; Ballinger, ML; Thomas, DM; Biesecker, B; Tucker, KM; Juraskova, I; Meiser, B; Schlub, T; Newson, AJ
2022-06Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.Vatter, S; Schlub, TE; Napier, CE; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, BB; Goldstein, D; Thomas, DM; Butow, P; Members of the PiGeOn Project,
2022-06Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Best, MC; members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project,; Jacobs, C
2022-02-14Staff perspectives on the feasibility of a clinical pathway for anxiety and depression in cancer care, and mid-implementation adaptations.Butow, P; Shepherd, HL; Cuddy, J; Rankin, N; Harris, M; He, S; Grimison, P; Girgis, A; Faris, M; ADAPT Program Group,; Shaw, J
2022-02Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.Butow, P; Davies, G; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, T; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project,
2022-02Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.Bartley, N; Best, MC; Biesecker, BB; Fisher, A; Goldstein, D; Meiser, B; Thomas, DM; Ballinger, ML; Butow, P
2021-11-17Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives.Butow, P; Shepherd, HL; Cuddy, J; Harris, M; He, S; Masya, L; Faris, M; Rankin, NM; Beale, P; Girgis, A; Kelly, B; Grimison, P; ADAPT Program Group,; Shaw, J
2021-11-10Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Tucker, K; Goldstein, D; Biesecker, BB; Best, MC; Members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project,
2021-11Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling.Butow, P; Müller, F; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, TE; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project,
2021-09-14Uptake of an online psychological therapy program (iCanADAPT-Early) when implemented within a clinical pathway in cancer care centres.Davies, F; Harris, M; Shaw, J; Butow, P; Newby, J; Murphy, M; Kirsten, L; ADAPT Program Group,; Shepherd, HL
2021-08Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.Bartley, N; Best, M; Butow, P
2021-07-26Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative studyVatter, S; Bartley, N; Best, M; Juraskova, I; Jacobs, C; Ballinger, ML; Thomas, DM; Butow, P
2021-05-18Online, Group-Based Psychological Support for Adolescent and Young Adult Cancer Survivors: Results from the Recapture Life Randomized TrialSansom-Daly, UM; Wakefield, CE; Ellis, SJ; McGill, BC; Donoghoe, MW; Butow, P; Bryant, RA; Sawyer, SM; Patterson, P; Anazodo, A; Plaster, M; Thompson, K; Holland, L; Osborn, M; Maguire, F; O'Dwyer, C; De Abreu Lourenco, R; Cohn, RJ; The Recapture Life Working Party,
2021Family communication about genomic sequencing: A qualitative study with cancer patients and relatives.Smit, AK; Bartley, N; Best, MC; Napier, CE; Butow, P; Newson, AJ; Tucker, K; Ballinger, ML; Thomas, DM; Jacobs, C; Meiser, B; Goldstein, D; Savard, J; Juraskova, I; PiGeOn authorship group,
2021Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results.Bartley, N; Napier, CE; Butt, Z; Schlub, TE; Best, MC; Biesecker, BB; Ballinger, ML; Butow, P
2020-10Cancer patients' views and understanding of genome sequencing: a qualitative study.Bartley, N; Best, M; Jacobs, C; Juraskova, I; Newson, AJ; Savard, J; Meiser, B; Ballinger, ML; Thomas, DM; Biesecker, B; Butow, P
2020-09Patient experience of uncertainty in cancer genomics: a systematic review.Bartley, N; Napier, C; Best, M; Butow, P
2020-09Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling.Davies, G; Butow, P; Napier, CE; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Thomas, DM; Schlub, TE; Best, MC; members of the PiGeOn Project,
2020-07-29The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients.Geerligs, L; Shepherd, HL; Rankin, NM; Masya, L; Shaw, JM; Price, MA; Dhillon, H; Dolan, C; Prest, G; ADAPT Program Group; Butow, P
2020-05-01Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer.Butow, P; Davies, G; Napier, CE; Schlub, T; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, B; Goldstein, D; Thomas, DM; PiGeOn Project,